Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7486

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907486)

FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)
This data provides evidence on the effectiveness of a treatment with a hazard ratio of 0.56 at a confidence interval of 95%. The p-value is less than 0.001, indicating statistical significance. The table also includes the number at risk over time for both the placebo and rosuvastatin groups.*
FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)
This text provides information on the number of events in a study comparing the effects of Roswa 20mg and Placebo 20mg. It includes data on various endpoints such as major cardiovascular events, cardiovascular death, stroke, MI, hospitalizations, unstable angina, and revascularization. The text also shows hazard ratios with confidence intervals and p-values for each endpoint. Additionally, it mentions that cardiovascular death includes fatal MI, fatal stroke, sudden death, and other adjudicated causes of cardiovascular death.*
FDA Label Image

Figure 3. (Rosuvastatin Fig3)

Figure 3. (Rosuvastatin Fig3)
This text provides information on the percent change from baseline in LDL-C levels after taking different doses of various statin medications including Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The doses evaluated for each medication are shown in milligrams (mg). This data is useful for comparing the efficacy of these statins in reducing LDL-C levels at different dosage levels.*
FDA Label Image

Chemical Structure (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.